Comparison of the effects of two doses of dexmedetomidine on physiological parameters and sedation in rabbits (Oryctolagus cuniculus)

Juliana Rizerio Moncayo

https://orcid.org/0009-0002-8902-7383

Brazil

Universidade de Santo Amaro image/svg+xml

Department of Veterinary Medicine

Andressa de Fátima Kotleski Thomas Lima

https://orcid.org/0000-0002-4795-208X

Brazil

Universidade de Santo Amaro image/svg+xml

Department of Veterinary Medicine

Filipe Aguera Pinheiro

https://orcid.org/0000-0001-6151-8581

Brazil

Universidade de Santo Amaro image/svg+xml

Department of Veterinary Medicine

Flavio Cunha

https://orcid.org/0009-0000-6656-398X

Brazil

Universidade de Santo Amaro image/svg+xml

Department of Veterinary Medicine

Thiago Bernardino

https://orcid.org/0000-0002-2146-0669

Brazil

Universidade de Santo Amaro image/svg+xml

Department of Veterinary Medicine

|

Accepted: 2026-04-15

|

Published: 2026-09-30

DOI: https://doi.org/10.4995/wrs.2026.24595
Funding Data

Downloads

Keywords:

healthy rabbits, cardiac output, dexmedetomidine, lagomorphs, sedation, α2-agonists, haemodynamic variables

Supporting agencies:

This research was not funded

Abstract:

This study aimed to evaluate the effects of dexmedetomidine (DEX) on cardiorespiratory, haemodynamic and glycaemic variables in rabbits, as well as to assess sedation using two different doses. Nineteen rabbits (14.31±12.64 months; 1.98±0.90 kg) were randomly assigned to two groups receiving 40 μg/kg (D40; n=10) or 60 μg/kg (D60; n=9) of DEX via intramuscular injection. Heart rate (HR), respiratory rate (RR), body temperature (T), invasive mean arterial pressure (IMAP), blood glucose (GLU) and cardiac output (CO) were evaluated at baseline (T1) and 15 min after drug administration (T2). Sedation was assessed using a descriptive numerical scale (0–13) adapted for rabbits. Both doses significantly reduced HR, IMAP, CO and RR, and increased GLU at T2 compared to baseline. No significant differences between groups were observed for physiological variables. However, sedation scores were significantly higher in the D60 group, with satisfactory sedation achieved in 89% of animals, compared to 30% in the D40 group. Both doses produced similar physiological effects, while the higher dose resulted in improved sedation quality. The evaluation at a single post-administration time point should be considered a limitation when interpreting these findings.

Show more Show less

References:

Bailey R.S., Barter L.S., Pypendop B.H. 2017. Pharmacokinetics of dexmedetomidine in isoflurane-anesthetized New Zealand White rabbits. Vet. Anaesth. Analg., 44: 876-882. https://doi.org/10.1016/j.vaa.2017.01.003

Bellini L., Banzato T., Contiero B., Zotti A. 2014. Evaluation of sedation and clinical effects of midazolam with ketamine or dexmedetomidine in pet rabbits. Vet. Rec., 175: 372. https://doi.org/10.1136/vr.102595

Borges O.M.M., Souza A.P., Lima D.A.S.D., Santana V.L., Araújo A.L., Figueiredo L.C.M., Neto P.I.N. 2012. Dexmedetomidine with ketamine or tiletamine/zolazepam in rabbits. Medvep - Rev. Cient. Med. Vet. Pequenos Animais de Estimação, 10: 8-13.

Brede M., Philipp M., Knaus A., Muthig V., Hein L. 2004. α2-Adrenergic receptor subtypes - Novel functions uncovered in gene-targeted mouse models. Biol. Cell, 96: 343-348. https://doi.org/10.1016/j.biolcel.2004.03.006

Brodbelt D.C., Blissitt K.J., Hammond R.A., Neath P.J., Young L.E., Pfeiffer D.U., Wood J.L.N. 2008. The risk of death: the confidential enquiry into perioperative small animal fatalities. Vet. Anaesth. Analg., 35: 365-373. https://doi.org/10.1111/j.1467-2995.2008.00397.x

Coats A.J.S. 1990. Doppler ultrasonic measurement of cardiac output: reproducibility and validation. Eur. Heart J., 11: 49-61. https://doi.org/10.1093/eurheartj/11.suppl_i.49

Costa G., Interlandi C. 2013. Infusion continues of dexmedetomidine in the rabbit. Riv. Uff. SCIVAC, 27: 51-56.

Grasso S.C., Ko J.C., Weil A.B., Paranjape V., Constable P.D. 2015. Hemodynamic influence of acepromazine or dexmedetomidine premedication in isoflurane-anesthetized dogs. J. Am. Vet. Med. Assoc., 246: 754-764. https://doi.org/10.2460/javma.246.7.754

Grint N.J., Murison P.J. 2007. Peri-operative body temperatures in isofluorane anaesthetized rabbits following ketaminemidazolam or ketamine-medetomidine. Vet. Anaesth. Analg., 34: 181-189. https://doi.org/10.1111/j.1467-2995.2006.00319.x

Harcourt-Brown F. 2001. Anaesthesia and analgesia. In: A textbook of rabbit medicine. Alden Press, Oxford, UK. https://doi.org/10.1016/B978-075064002-2.50008-4

Kamibayashi T., Maze M., Weiskopf R.B., Todd M.M. 2000. Clinical uses of α2-adrenergic agonists. Anesthesiology, 93: 1345-1349. https://doi.org/10.1097/00000542-200011000-00030

Lima D.A.S.D., Souza A.P., Borges O.M.M., Santana V.L., Araújo A.L., Figueiredo L.C.M., Nóbrega Neto P.I., Lima W.C. 2014. Comparative study of the association of ketamine to dexmedetomidine, medetomidine or xylazine in rabbits. Rev. Bras. Med. Vet., 36: 35-41.

Lord B., Boswood A., Petrie A. 2010. Electrocardiography of the normal domestic pet rabbit. Vet. Rec., 167: 961-965. https://doi.org/10.1136/vr.c3212

Marín P., Belda E., Laredo F.G., Torres C.A., Hernandis V., Escudero E. 2020. Pharmacokinetics and sedative effects of alfaxalone with or without dexmedetomidine in rabbits. Res. Vet. Sci., 129: 6-12. https://doi.org/10.1016/j.rvsc.2019.12.015

Moens Y. 2000. The veterinary experience. Bailliere’s Clin. Anaesth., 14: 293-304. https://doi.org/10.1053/bean.2000.0084

Nishida T., Nishimura M., Kagawa K., Hayashi Y., Mashimo T. 2002. The effects of dexmedetomidine on the ventilatory response to hypercapnia in rabbits. Intensive Care Med., 28: 969-975. https://doi.org/10.1007/s00134-002-1338-y

Pan S.Y., Liu G., Lin J.H., Jin Y.P. 2021. Efficacy and safety of dexmedetomidine premedication in balanced anesthesia: a systematic review and meta-analysis in dogs. Animals, 11: 3254. https://doi.org/10.3390/ani11113254

Raekallio M., Ansah O.B., Kuusela E., Vainio O. 2002. Some factors influencing the level of clinical sedation induced by medetomidine in rabbits. J. Vet. Pharmacol. Ther., 25: 39-42. https://doi.org/10.1046/j.1365-2885.2002.00382.x

Ren J., Li C., Ma S., Wu J., Yang Y. 2018. Impact of dexmedetomidine on hemodynamics in rabbits. Acta Cir. Bras., 33: 314-323. https://doi.org/10.1590/s0102-865020180040000003

Restitutti F., Raekallio M., Vainionpää M., Kuusela E., Vainio O. 2012. Plasma glucose, insulin, free fatty acids, lactate and cortisol concentrations in dexmedetomidine-sedated dogs with or without MK-467: A peripheral α-2 adrenoceptor antagonist. Vet. J., 193: 481-485. https://doi.org/10.1016/j.tvjl.2011.12.010

Rezende M.L., Nunes N., Souza A.P., Santos P.S.P. 2002. Monitoramento hemodinâmico invasivo em pequenos animais. Ciênc. Agrár., 23: 93. https://doi.org/10.5433/1679-0359.2002v23n1p93

Siegenthaler J., Pleyers T., Raillard M., Spadavecchia C., Levionnois O.L. 2020. Effect of medetomidine, dexmedetomidine, and their reversal with atipamezole on the nociceptive withdrawal reflex in beagles. Animals, 10: 1-14. https://doi.org/10.3390/ani10071240

Sinclair M.D. 2003. A review of the physiological effects of α2-agonists related to the clinical use of medetomidine in small animal practice. Can. Vet. J., 44: 885-897.

Stypmann J., Engelen M.A., Breithardt A.K., Milberg P., Rothenburger M., Breithardt O.A., Breithardta G., Eckardta L., Cordula P.N. 2007. Doppler echocardiography and tissue doppler imaging in the healthy rabbit: differences of cardiac function during awake and anaesthetized examination. Int. J. Cardiol., 115: 165-170. https://doi.org/10.1016/j.ijcard.2006.03.006

Szumita P.M., Baroletti S.A., Anger K.E., Wechsler M.E. 2007. Sedation and analgesia in the intensive care unit: evaluating the role of dexmedetomidine. Am. J. Health Syst. Pharm., 64: 37-44. https://doi.org/10.2146/ajhp050508

Uehara Y., Koga M., Takahashi M. 1995. Determination of cardiac output by echocardiography. J. Vet. Med. Sci., 57: 401-407. https://doi.org/10.1292/jvms.57.401

Wu J., Lei E., Zhou J., Zhao D. 2017. Impacts and mechanisms of dexmedetomidine HCl on heart rate in rabbit with bilateral vagotomy or sympathectomy. Biomed. Res. (India), 28: 7509-7513.

Xu H., Aibiki M., Seki K., Ogura S., Ogli K. 1998. Effects of dexmedetomidine, an α2-adrenoceptor agonist, on renal sympathetic nerve activity, blood pressure, heart rate and central venous pressure in urethane-anesthetized rabbits. J. Auton. Nerv. Syst., 71: 48-54. https://doi.org/10.1016/s0165-1838(98)00061-7

Yanmaz L.E., Okur S., Turgut F., Golgeli A. 2022. Effects of intramuscular and intranasal administration of midazolam–dexmedetomidine on sedation and some cardiopulmonary variables in New Zealand White rabbits. Vet. Anaesth. Analg., 49: 113-117. https://doi.org/10.1016/j.vaa.2021.10.003

Zornow M.H. 1991. Ventilatory, hemodynamic and sedative effects of the α2 adrenergic agonist, dexmedetomidine. Neuropharmacology, 30: 1065-1071. https://doi.org/10.1016/0028-3908(91)90135-x

Zornow M.H., Scheller M.S., Sheehan P.B., Strnat M.A.P., Matsumoto M. 1992. Intracranial pressure effects of dexmedetomidine in rabbits. Anesth. Analg., 75: 232-237. https://doi.org/10.1213/00000539-199208000-00014

Show more Show less